arrow_back Back to App

Facilitating Innovative Nuclear Diagnostics Act of 2021

This act aims to ensure that individuals covered by Medicare preserve access to modern diagnostic scans using radiopharmaceuticals. These changes mean hospitals will receive separate payments for these procedures, aiming to ensure equitable payment under the prospective payment system.
Key points
Introduction of separate payments for certain diagnostic radiopharmaceuticals under Medicare, instead of packaging their costs.
Medicare beneficiaries will not see changes in their copayments as a result of these regulations.
Changes take effect for services furnished on or after January 1, 2022.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_2609
Sponsor: Sen. Blackburn, Marsha [R-TN]
Process start date: 2021-08-04